ÂÜÀòÂÒÂ×

Amy Barker is a Principal Scientist at Oxford Biomedica since November 2019, specializing in early-stage onboarding and feasibility work for new clients, focusing on characterizing products within the LentiVector platform. Prior to this role, Amy served as a Senior Scientist in dynamic projects involving product optimization and initial studies before scale-up. Amy's earlier experience includes postdoctoral positions at the University of Oxford and Queen Mary University of London, where significant research on protein analysis and trafficking was conducted. Academic qualifications include a DPhil in Molecular and Cellular Parasitology from the University of Oxford and a BSc in Microbiology from The University of Manchester.